Research Antibodies Market Size to Exceed USD 11.81 Billion by 2033, Driven by Rising Investment in R&D

Research Antibodies Market Outlook

Antibodies are immune system proteins produced in response to the appearance of a pathogen (known as an antigen). Research antibodies detect an unconjugated primary antibody, which is then used to target an antigen. Research laboratory procedures, such as western blotting and others, rely on research antibodies, which are indispensable tools for these procedures. Antibodies used in scientific research are crucial detection methods. Antibodies can also be used to designate and identify specific proteins present in a diseased cell at a specific stage of the disease's life cycle to determine why a cell function has gone awry.

According to Straits Research, the global research antibodies market size was valued at USD 6.97 billion in 2024 and is anticipated to grow from USD 7.39 billion in 2025 to reach USD 11.81 billion in 2033, growing at a CAGR of 6.03% during the forecast period (2025-2033).

Download the Sample Pages of this Report for Better Understanding @ https://straitsresearch.com/report/research-antibodies-market/request-sample

Market Dynamics

Increasing Investment in R&D Drives the Global Market

Numerous prominent biopharmaceutical, pharmaceutical, and biotechnology firms have increased their R&D efforts to develop innovative antibodies, including monoclonal antibodies. In 2016, Novartis invested USD 9 billion in research and development, whereas Pfizer invested USD 7.9 billion to develop novel products and technologies in the same year. In addition, research antibodies are complex and sophisticated structures increasingly utilized in research and academic institutions and by major pharmaceutical and biotechnology companies, thereby garnering R&D investments to develop advanced generations of antibodies. The frequency of cancer and other chronic diseases has increased the demand for research and development in research antibodies, driving market growth.

Growing Products Launches by Industry Participants Create Tremendous Opportunities

Participants in the market are working on product approvals, which are expected to accelerate the growth of the global market for research antibodies over the forecast period. For instance, the U.S. FDA approved Tepezza (TM) (teprotumumab-trbw), a therapeutic monoclonal antibody for treating thyroid eye disease, on January 21, 2020. In addition, Horizon Therapeutics plc is a biopharmaceutical corporation devoted to pharmaceutical research, development, and marketing (TED). TED is an uncommon, severe, and vision-threatening autoimmune disease that causes proptosis (eye bulging), diplopia (double vision), impaired vision, discomfort, inflammation, and facial deformities. Tepezza is the only treatment for TED that has been approved by the FDA (Food and Drug Administration) of the United States. These factors are anticipated to provide market expansion opportunities.

Global Research Antibodies Market: Segmentation

By Product
Primary Antibodies
Secondary Antibodies

By Type
Monoclonal Antibodies
Polyclonal Antibodies

By Technology
Immunohistochemistry
Immunofluorescence
Western Blotting
Flow Cytometry
Immunoprecipitation
Enzyme-linked Immunoassay
Others

By Source
Mouse
Rabbit
Goat
Others

By Applications
Infectious Diseases
Immunology
Oncology
Stem Cells
Neurobiology
Others

By End-User
Academic and Research Institutes
Contract Research Organizations
Pharmaceutical and Biotechnological Companies

Get Detailed Market Segmentation @ https://straitsresearch.com/report/research-antibodies-market/segmentation

Key Highlights

Based on the product, the global research antibodies market is bifurcated into primary and secondary antibodies. The primary antibodies segment is the most significant contributor to the market share and is anticipated to exhibit a CAGR of 6.31% over the forecast period.

Based on type, the global research antibodies market is divided into monoclonal and polyclonal antibodies. The monoclonal antibody segment dominates the global market and is projected to exhibit a CAGR of 6.5% over the forecast period.

Based on technology, the global research antibodies market is bifurcated into immunohistochemistry, western blotting, immunofluorescence, flow cytometry, ELISA, immunoprecipitation, and others. The western blotting segment is the most significant contributor to the market share and is anticipated to exhibit a CAGR of 5.71% over the forecast period.

Based on the source, the global research antibodies market is segmented into mouse, rabbit, goat, and others. The mouse segment is the largest revenue contributor to the market and is projected to exhibit a CAGR of 6.1% over the forecast period.

Based on application, the global research antibodies market is divided into infectious diseases, oncology, immunology, neurobiology, stem cells, and others. The oncology segment dominates the global market and is expected to grow at a CAGR of 5.71% over the forecast period.

Based on end-user, the global research antibodies market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations. The pharmaceutical and biotechnology companies segment owns the highest market share and is projected to exhibit a CAGR of 6.5% during the forecast period.

North America is the most significant global research antibodies market shareholder and is anticipated to exhibit a CAGR of 4.8% during the forecast period.

Competitive Players

Abcam Plc
Merck Millipore
Thermo Fisher Scientific, Inc.
Cell Signaling Technology, Inc.
PerkinElmer, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories
Lonza Group
Agilent Technologies
F. Hoffmann La Roche Ltd

To Visit Here For Grab More Insights @ https://straitsresearch.com/report/research-antibodies-market

Regional Analysis

North America is the most significant global research antibodies market shareholder and is anticipated to exhibit a CAGR of 4.8% during the forecast period. The United States and Canada are North America's most important nations. Antibody industry growth in North America is anticipated to be fueled by novel product introductions. The presence of numerous biotechnology and biopharmaceutical manufacturers, research institutes, and substantial economic growth are significant factors driving the North American market for research antibodies. In addition, the manufacturers of research antibodies concentrate on developing, marketing, and distributing innovative products to meet the requirements of researchers and healthcare professionals. High healthcare costs in North America propel the market for research antibodies.

Europe is estimated to exhibit a CAGR of 5.2% over the forecast period. The substantial proportion attained by the region is a result of the increase in research activities over the past few years. Consistent growth has encouraged researchers to utilize advanced reagents and antibodies to accelerate research, contributing to market expansion. Affinomics, a program launched by the European Union (EU) to promote the adoption of recombinant technologies, is among the main factors responsible for expanding growth prospects over the past few years. This region's development is accelerated by the increasing number of initiatives by clinicians and scientists to raise awareness of the availability of various types of antibodies suited to specific research needs. In addition, antibody production guidelines issued by public organizations assure the quality of research antibodies, resulting in a greater reliance on researchers and clinicians, contributing to the demand for research antibodies in the coming years.

Recent Developments

In April 2023, Astellas Pharma and Twist Bioscience partnered to assist the former with discovering antibodies for immunotherapies.

In April 2023, Innate Pharma SA revealed that it had signed an exclusive license contract with Takeda. Under the terms of the agreement, Innate allows Takeda exclusive global rights to research and develop antibody-drug conjugates (ADC) using a panel of selected Innate antibodies against an undisclosed target, with a primary focus on Celiac disease.

Inquiry Before Buying @ https://straitsresearch.com/buy-now/research-antibodies-market

List of Related Reports:

Antibodies Market Size: https://straitsresearch.com/report/antibodies-market

Bispecific Antibodies Market Size: https://straitsresearch.com/report/bispecific-antibodies-market

Monoclonal Antibodies Market size: https://straitsresearch.com/report/monoclonal-antibodies-market

Biosimilar Monoclonal Antibodies Market Size: https://straitsresearch.com/report/biosimilar-monoclonal-antibodies-market

Immunohistochemistry Market Size: https://straitsresearch.com/report/immunohistochemistry-market

Flow Cytometry Market Size: https://straitsresearch.com/report/flow-cytometry-market

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/

About Us:

StraitsResearch.com is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services, along with providing business insights & market research reports.

This release was published on openPR.